<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03565575</url>
  </required_header>
  <id_info>
    <org_study_id>P67251_PrEP</org_study_id>
    <secondary_id>1R01MH114562-01</secondary_id>
    <nct_id>NCT03565575</nct_id>
  </id_info>
  <brief_title>Manicaland PrEP Uptake Through Interactive Counselling Trial</brief_title>
  <official_title>Improving Risk Perception and Uptake of Pre-exposure Prophylaxis (PrEP) Through Interactive Feedback Based Counselling (and Community Engagement) in Young Women in Manicaland</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Simon Gregson</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biomedical Research and Training Institute, Zimbabwe</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>London School of Economics and Political Science</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary Objective:&#xD;
&#xD;
      The purpose of this trial is to evaluate the impact of an interactive tablet based&#xD;
      counselling session correcting risk perception and addressing ambiguity around availability,&#xD;
      usability and effectiveness of PrEP on PrEP uptake within 6 months in adolescent girls and&#xD;
      young women (AGYW) aged 18-24 years.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      Correcting misperceptions of risks of HIV infection and off-setting ambiguity effects about&#xD;
      the availability, usability and efficacy of PrEP, through localized, interactive,&#xD;
      tablet-based counselling, will increase uptake of PrEP in HIV-negative AGYW.&#xD;
&#xD;
      Study outcomes:&#xD;
&#xD;
      The primary outcomes for the study will be risk perception measured in a follow-up survey at&#xD;
      6 months and proportion of women taking up PrEP within 6 months measured with biomarkers of&#xD;
      plasma antiretroviral (ARV) drug presence.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 7, 2018</start_date>
  <completion_date type="Actual">January 30, 2021</completion_date>
  <primary_completion_date type="Actual">July 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Uptake of Pre-exposure prophylaxis for HIV</measure>
    <time_frame>6 months</time_frame>
    <description>The proportion of women taking up PrEP within 6 months measured with biomarkers of plasma ARV presence.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in perception of risk of HIV</measure>
    <time_frame>6 months</time_frame>
    <description>Risk perception with be measured in a follow-up survey at 6 months</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1055</enrollment>
  <condition>Improving Perceptions of HIV Risk</condition>
  <condition>Improving Uptake of Pre-exposure Prophylaxis for HIV</condition>
  <arm_group>
    <arm_group_label>Interactive tablet-based quiz</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals participate in an interactive tablet-based risk perception and PrEP counselling information session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention will be administered to the control arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interactive tablet-based quiz</intervention_name>
    <description>Intervention participants play an interactive tablet based quiz including the following information components:&#xD;
Risks of HIV infection under different scenarios such as between two hypothetical individuals and with different behaviours.&#xD;
Interactive counselling on key facts around PrEP, its usability and local availability&#xD;
All individuals will have the option to sign up for contact by a nurse from the health clinic to discuss PrEP further and make an appointment for a visit. Participants will also be given a PrEP referral letter which they can present directly at one of the participating study clinics to begin PrEP. In two sites a community-led intervention will also be implemented to address social obstacles and to increase support from peers, families and social structures.</description>
    <arm_group_label>Interactive tablet-based quiz</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women&#xD;
&#xD;
          -  Age 18-24 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants testing HIV-positive at baseline&#xD;
&#xD;
          -  Self-reporting taking PrEP at baseline&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Participant eligibility is based on self-representation of gender identity.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simon Gregson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Manicaland Centre for Public Health Research</name>
      <address>
        <city>Bonda</city>
        <state>Manicaland</state>
        <country>Zimbabwe</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manicaland Centre for Public Health Research</name>
      <address>
        <city>Eastern Highlands</city>
        <state>Manicaland</state>
        <country>Zimbabwe</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manicaland Centre for Public Health Research</name>
      <address>
        <city>Hobhouse</city>
        <state>Manicaland</state>
        <country>Zimbabwe</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manicaland Centre for Public Health Research</name>
      <address>
        <city>Honde</city>
        <state>Manicaland</state>
        <country>Zimbabwe</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manicaland Centre for Public Health Research</name>
      <address>
        <city>Nyazura</city>
        <state>Manicaland</state>
        <country>Zimbabwe</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manicaland Centre for Public Health Research</name>
      <address>
        <city>Sakubva</city>
        <state>Manicaland</state>
        <country>Zimbabwe</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manicaland Centre for Public Health Research</name>
      <address>
        <city>Selbourne</city>
        <state>Manicaland</state>
        <country>Zimbabwe</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manicaland Centre for Public Health Research</name>
      <address>
        <city>Nyanga</city>
        <country>Zimbabwe</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Zimbabwe</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 11, 2018</study_first_submitted>
  <study_first_submitted_qc>June 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2018</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Imperial College London</investigator_affiliation>
    <investigator_full_name>Simon Gregson</investigator_full_name>
    <investigator_title>Professor of Demography and Behavioural Science</investigator_title>
  </responsible_party>
  <keyword>Pre-Exposure Prophylaxis (PrEP) for HIV</keyword>
  <keyword>Risk perception</keyword>
  <keyword>HIV</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

